← Human Trials & Peer-Reviewed Studies
Linear and knemometric growth in the early phase of rehabilitation from severe malnutrition.
Plain-language guide to PMID 11430781 (2001): double-blind randomized controlled trial of Zinc Sulfate in 141 children.
Key Facts
- PMID
- 11430781
- Journal
- The British journal of nutrition
- Year
- 2001
- Study type
- Randomized Controlled Trial
- Authors
- Doherty CP et al. (6 authors)
- DOI
- 10.1079/bjn2001351
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Zinc Sulfate.
The relationship between ponderal, linear and lower leg growth in children recovering from severe malnutrition remains unclear.
Mean (sd) weight for height (WHZ) and height for age (HAZ) catch-up growth z scores over the 90 d were 1.6 (0.85) and 0.47 (0.325) respectively.
Who Took Part
According to the abstract, 141 children were involved.
By PubMed's age tags, the people studied were infants and young children.
The researchers report on the early growth of 141 severely malnourished Bangladeshi children aged 6 to 36 months of age who were followed for 90 d.
How the Study Was Run
The design is described as randomized and double-blind.
The children were allocated by chance, so the Zinc Sulfate group and the comparison group should start out alike.
Neither the children nor the staff measuring them knew who was on Zinc Sulfate, so expectations could not easily colour the readings.
What Was Measured
Mean (sd) weight for height (WHZ) and height for age (HAZ) catch-up growth z scores over the 90 d were 1.6 (0.85) and 0.47 (0.325) respectively.
PubMed files the paper under topics including Anthropometry, Body Height, Growth, Leg, Protein-Energy Malnutrition, Regression Analysis and Zinc Sulfate.
What This Means in Plain Language
The paper is a randomized and double-blind study of Zinc Sulfate in 141 children.
The publication is from 2001 (The British journal of nutrition), a journal based in England.
More context: all human trials.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.